Figure 2
Figure 2. Effect of miR-130a on Smad4 expression. (A) HEK293 cells were transfected with miR-130a and a scrambled pre-miR (miR-neg), respectively. The immunoblot shows down-regulation of Smad4 protein in cells transfected with pre-miR-130a compared with scramble pre-miR at 48 hours. The graph displays the relative expression of Smad4, normalized to β-actin expression. The experiment was repeated 3 times with similar results. (B) The relative expression of Smad4 mRNA in HEK293 cells transfected with pre–miR-130a and miR-neg as in panel A. The Smad4 mRNA level was measured by real-time PCR and normalized to β-actin expression. Data are shown as the mean ± SD from triplicate measurements. (C) Western blot analysis showing the expression level of Smad4 protein in A549 cells transfected with siRNA-Smad4, pre–miR-130a, miR-neg, or siRNA-neg at 48 hours after transfection. The graph shows the relative expression of Smad4 normalized to β-actin expression. (D) The relative expression level of Smad4 mRNA in A549 cells transfected with siRNA-Smad4, pre–miR-130a, miR-neg, or siRNA-neg at 48 hours after transfection. Smad4 mRNA expression was measured by real-time PCR and normalized to β-actin expression. Data are shown as the mean ± SD from triplicate measurements. (E) A549 cells were cotransfected with a TGF-β inducible firefly luciferase reporter plasmid (CAGA12-MLP-Luc) that carries the Smad-binding element of the plasminogen activator inhibitor-1 gene, a renilla luciferase reporter for normalization of transfection, and with siRNA-Smad4, pre–miR-130a, miR-neg, or siRNA-neg, respectively. The cells were cultured in standard medium for 24 hours and then incubated with or without human recombinant TGF-β1 (20nM) for an additional 6 hours before determination of luciferase activity by use of the Dual-Luciferase Reporter Assay System. The experiment was repeated 3 times with similar results. The highest value in the transfection series was assigned the value 1, and the relative expression of the other samples was recalculated accordingly.

Effect of miR-130a on Smad4 expression. (A) HEK293 cells were transfected with miR-130a and a scrambled pre-miR (miR-neg), respectively. The immunoblot shows down-regulation of Smad4 protein in cells transfected with pre-miR-130a compared with scramble pre-miR at 48 hours. The graph displays the relative expression of Smad4, normalized to β-actin expression. The experiment was repeated 3 times with similar results. (B) The relative expression of Smad4 mRNA in HEK293 cells transfected with pre–miR-130a and miR-neg as in panel A. The Smad4 mRNA level was measured by real-time PCR and normalized to β-actin expression. Data are shown as the mean ± SD from triplicate measurements. (C) Western blot analysis showing the expression level of Smad4 protein in A549 cells transfected with siRNA-Smad4, pre–miR-130a, miR-neg, or siRNA-neg at 48 hours after transfection. The graph shows the relative expression of Smad4 normalized to β-actin expression. (D) The relative expression level of Smad4 mRNA in A549 cells transfected with siRNA-Smad4, pre–miR-130a, miR-neg, or siRNA-neg at 48 hours after transfection. Smad4 mRNA expression was measured by real-time PCR and normalized to β-actin expression. Data are shown as the mean ± SD from triplicate measurements. (E) A549 cells were cotransfected with a TGF-β inducible firefly luciferase reporter plasmid (CAGA12-MLP-Luc) that carries the Smad-binding element of the plasminogen activator inhibitor-1 gene, a renilla luciferase reporter for normalization of transfection, and with siRNA-Smad4, pre–miR-130a, miR-neg, or siRNA-neg, respectively. The cells were cultured in standard medium for 24 hours and then incubated with or without human recombinant TGF-β1 (20nM) for an additional 6 hours before determination of luciferase activity by use of the Dual-Luciferase Reporter Assay System. The experiment was repeated 3 times with similar results. The highest value in the transfection series was assigned the value 1, and the relative expression of the other samples was recalculated accordingly.

Close Modal

or Create an Account

Close Modal
Close Modal